SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
38.51
-0.30 (-0.77%)
At close: Aug 22, 2025, 2:57 PM CST
-0.77%
Market Cap3.04B
Revenue (ttm)795.66M
Net Income (ttm)91.12M
Shares Out79.00M
EPS (ttm)1.08
PE Ratio35.72
Forward PE27.91
Dividend0.25 (0.65%)
Ex-Dividend DateJun 20, 2025
Volume1,581,930
Average Volume2,995,612
Open38.78
Previous Close38.81
Day's Range38.39 - 39.07
52-Week Range23.07 - 44.30
Beta0.95
RSI49.08
Earnings DateAug 29, 2025

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company’s SMO services include preliminary model establishment, preliminary plan preparation, initiation of clinical trial sites, on-site implementation, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,416
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2024, SMO ClinPlus CO.,LTD.'s revenue was 803.73 million, an increase of 5.75% compared to the previous year's 760.04 million. Earnings were 106.43 million, a decrease of -21.01%.

Financial Statements

News

There is no news available yet.